A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer
Abstract Background Programmed cell death-1 (PD-1) immune checkpoint inhibitor antibody has proven to be effective in advanced non-small cell lung cancer (NSCLC) patients positive for programmed cell death-1 ligand-1 (PD-L1). However, there are currently no prospective studies evaluating PD-L1 expre...
Main Authors: | Akihito Tsunoda, Kei Morikawa, Takeo Inoue, Teruomi Miyazawa, Masahiro Hoshikawa, Masayuki Takagi, Masamichi Mineshita |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5773-3 |
Similar Items
-
Drastic healing process after pembrolizumab monotherapy in a case of advanced squamous cell carcinoma with severe bronchial stenosis observed over a two‐year period using continuous bronchoscopy: A case report
by: Kei Morikawa, et al.
Published: (2020-05-01) -
Probe‐based confocal laser endomicroscopy for rapid on‐site evaluation of transbronchial biopsy specimens
by: Masao Takemura, et al.
Published: (2019-06-01) -
Flexible bronchoscopy-guided vocal cord biopsy under conscious sedation: An option to surgical biopsy in special situations
by: Ravindra M Mehta, et al.
Published: (2019-01-01) -
Utility of Cell-Block of Bronchial Washings in Diagnosis of Lung Cancer- A Comparative Analysis with Conventional Smear Cytology
by: Uday C Kakodkar, et al.
Published: (2016-04-01) -
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Diagnosis of Hilar and Mediastinal Lymph Node Metastases of Melanoma
by: José-Fernando VAL-BERNAL, et al.
Published: (2019-05-01)